Literature DB >> 9457970

In vivo demonstration of impaired microcirculation in steatotic human liver grafts.

A M Seifalian1, V Chidambaram, K Rolles, B R Davidson.   

Abstract

The perfusion of human donor livers was studied during organ retrieval using laser Doppler flowmetry to assess the microcirculatory alteration caused by fatty infiltration (steatosis). Using a multichannel laser Doppler flowmeter, we measured the hepatic perfusion as flux units in 21 liver donors, eight of which were macroscopically fatty. Perfusion was recorded continuously for 2 minutes from two sites on each lobe at the beginning of organ retrieval, after the vascular dissection, and during sequential occlusion of the hepatic artery and portal vein. Mean flux value and SEM were calculated, and paired Student's t test was used for comparison between stages of perfusion. Multiple ANOVA was used to determine whether factors other than the normal or fatty parenchyma influenced the perfusion measurements. Mobilization of the graft did not affect parenchymal perfusion. Perfusion was significantly (P < 0.001) and rapidly reduced with hepatic artery or portal vein occlusion in both groups. Macroscopically steatotic livers (n = 8) had diminished microcirculation compared with normal livers (n = 13) (125 +/- 18 v 252 +/- 24 flux units; P = 0.002). Donors receiving inotropes (n = 10) had a lower mean perfusion rate (150 +/- 20 v 252 +/- 29 flux units; P = 0.026), but this effect was found in both the normal and steatotic groups with no interaction (ANOVA; P = 0.658). Steatosis diminishes the tissue perfusion in human liver grafts. Laser Doppler flowmetry may help identify grafts with a compromised microcirculation.

Entities:  

Mesh:

Year:  1998        PMID: 9457970     DOI: 10.1002/lt.500040110

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  33 in total

1.  Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging.

Authors:  James T Lee; Joy Liau; Paul Murphy; Michael E Schroeder; Claude B Sirlin; Mark Bydder
Journal:  Magn Reson Imaging       Date:  2012-01-27       Impact factor: 2.546

Review 2.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

3.  Surgical outcome of right liver donors in living donor liver transplantation: single-center experience with 500 cases.

Authors:  Say-June Kim; Gun-Hyung Na; Ho-Joong Choi; Young-Kyung Yoo; Dong-Goo Kim
Journal:  J Gastrointest Surg       Date:  2012-03-17       Impact factor: 3.452

4.  Day-of-surgery rejection of donors in living donor liver transplantation.

Authors:  Bassem Hegab; Mohamed Rabei Abdelfattah; Ayman Azzam; Hazem Mohamed; Waleed Al Hamoudi; Faisal Aba Alkhail; Hamad Al Bahili; Hatem Khalaf; Mohammed Al Sofayan; Mohammed Al Sebayel
Journal:  World J Hepatol       Date:  2012-11-27

5.  Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities.

Authors:  Hui Dong; Fu'er Lu; Nan Wang; Xin Zou; Jingjing Rao
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

6.  Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation.

Authors:  Peter T W Kim; Giovanna Saracino; Linda Jennings; Michael Ramsay; Gregory J McKenna; Giuliano Testa; Tiffany L Anthony; Nicholas Onaca; Richard M Ruiz; Robert M Goldstein; Marlon F Levy; Goran B Klintmalm
Journal:  HPB (Oxford)       Date:  2014-07-18       Impact factor: 3.647

Review 7.  Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.

Authors:  Hirotaka Tashiro; Shintaro Kuroda; Yoshihiro Mikuriya; Hideki Ohdan
Journal:  Surg Today       Date:  2014-09       Impact factor: 2.549

8.  Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition.

Authors:  Xiangdong Wang; Christopher J Walkey; Ana C Maretti-Mira; Lei Wang; Deborah L Johnson; Laurie D DeLeve
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

9.  Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.

Authors:  Rohan C Siriwardana; See Ching Chan; Kenneth S H Chok; Chung Mau Lo; Sheung Tat Fan
Journal:  HPB (Oxford)       Date:  2012-05-29       Impact factor: 3.647

10.  Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.

Authors:  Marie Liebig; Alireza Hassanzada; Malte Kämmerling; Berit Genz; Brigitte Vollmar; Kerstin Abshagen
Journal:  Exp Biol Med (Maywood)       Date:  2017-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.